Boston Scientific

BSX.US surged about 4.7% today, rallying in a single-leg upward move from 43.465 to close near the session high at 45.100, driven by news of its acquisition of Valencia Technologies (maker of the eCoin overactive bladder device) and a short squeeze—June short interest fell 48.3%. Q1 EPS doubled YoY to $0.90, net margin rose to 25.8%, and revenue grew 11.6% YoY to $5.23B; however, the stock remains 58.8% below its 52-week high of $109.50 and has declined 52.4% YTD, trading under both its 20-day ($45.93) and 60-day ($53.43) moving averages, though the 52-week low of $42.25 provides near-term support.